JPS6115843A - 癌転移抑制剤 - Google Patents

癌転移抑制剤

Info

Publication number
JPS6115843A
JPS6115843A JP59135161A JP13516184A JPS6115843A JP S6115843 A JPS6115843 A JP S6115843A JP 59135161 A JP59135161 A JP 59135161A JP 13516184 A JP13516184 A JP 13516184A JP S6115843 A JPS6115843 A JP S6115843A
Authority
JP
Japan
Prior art keywords
cancer
lysozyme
drug
present
platelet aggregation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59135161A
Other languages
English (en)
Japanese (ja)
Other versions
JPH051244B2 (enrdf_load_stackoverflow
Inventor
Kiyoshi Saito
清 斉藤
Naoyuki Nishimura
直行 西村
Osamu Irino
入野　理
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co Ltd filed Critical Grelan Pharmaceutical Co Ltd
Priority to JP59135161A priority Critical patent/JPS6115843A/ja
Publication of JPS6115843A publication Critical patent/JPS6115843A/ja
Publication of JPH051244B2 publication Critical patent/JPH051244B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP59135161A 1984-07-02 1984-07-02 癌転移抑制剤 Granted JPS6115843A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59135161A JPS6115843A (ja) 1984-07-02 1984-07-02 癌転移抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59135161A JPS6115843A (ja) 1984-07-02 1984-07-02 癌転移抑制剤

Publications (2)

Publication Number Publication Date
JPS6115843A true JPS6115843A (ja) 1986-01-23
JPH051244B2 JPH051244B2 (enrdf_load_stackoverflow) 1993-01-07

Family

ID=15145245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59135161A Granted JPS6115843A (ja) 1984-07-02 1984-07-02 癌転移抑制剤

Country Status (1)

Country Link
JP (1) JPS6115843A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7791444B2 (en) 2008-02-29 2010-09-07 Tdk Corporation Balun transformer using a drum-shaped core

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533409A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Carcinostatic agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533409A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Carcinostatic agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7791444B2 (en) 2008-02-29 2010-09-07 Tdk Corporation Balun transformer using a drum-shaped core

Also Published As

Publication number Publication date
JPH051244B2 (enrdf_load_stackoverflow) 1993-01-07

Similar Documents

Publication Publication Date Title
US11033532B2 (en) Uses of benzimidazole derivative for nocturnal acid breakthrough
KR100849999B1 (ko) 두통, 편두통, 구역질 및 구토를 위한 약학적 조성물
RU2592983C2 (ru) Комбинированная терапия, включающая вемурафениб и интерферон, для применения в лечении рака
JP3041232B2 (ja) 癌転移抑制剤
US4746668A (en) Method for treating retinopathy
EA029000B1 (ru) КОМБИНАЦИЯ БОРТЕЗОМИДА И Akt-ИНГИБИТОРА ДЛЯ ЛЕЧЕНИЯ МНОЖЕСТВЕННОЙ МИЕЛОМЫ
ES2470369T3 (es) Inhibidores de la expresión de TGF-a
JPS59199630A (ja) 卵巣機能低下症治療剤
JPS6328045B2 (enrdf_load_stackoverflow)
CN107334767A (zh) 一种哒嗪酮类化合物在肿瘤治疗中的应用
JPS6115843A (ja) 癌転移抑制剤
KR950007101B1 (ko) 소화성 궤양 치료제
WO1992004028A1 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
DK165966B (da) Forbedret piroxicamholdigt anti-inflammatorisk praeparat
Goldblatt et al. Studies on Experimental Hypertension: XVII. Experimental Observations on the Treatment of Hypertension
JPS6248622A (ja) 癌転移抑制剤
ES2396468T3 (es) Composiciones para uso en el tratamiento del síndrome mielodisplástico
RU2181286C2 (ru) Кардиотоническое и гипертензивное средство, длительно повышающее давление, и лекарственные формы на его основе
CA2191230C (en) 2-halo-2'-deoxyadenosine treatment for inflammatory bowel disease
JP2000026295A (ja) 虚血再潅流損傷の治療薬ならび不整脈および心筋梗塞による心不全を含む細胞機能障害の治療薬
AU2022207001B2 (en) Application of cilostazol-containing composition in preparing drug for treating cerebrovascular disease
MXPA06003056A (es) Tratamiento de tumores estromales gastrointestinales con imatinib y midostaurin.
CN116196314B (zh) Ri-1或其盐在制备防治胃肠道疾病的药物中的应用
TWI676477B (zh) 苯并咪唑衍生物用於夜間酸突破的用途
KR20020031404A (ko) 혈장 대체 조성물